Task: Answer the multiple choice question.
Question: Which drug exhibits a -25.730\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCOC(=O)NC(C)N1C(=O)C2C3C=CC(C3)C2C1=O
b) CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1
c) CCC(C)N(NC(C)=O)c1nc(Cl)nc(NC(C)C)n1
Answer: b. CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1
CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1
1-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propan-1-one